Profile data is unavailable for this security.
About the company
Sigyn Therapeutics, Inc. (Sigyn) is a development-stage company. The Company is focused on creating therapeutic solutions that address unmet needs in global health. The Company's product candidate, Sigyn Therapy, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders. Its treatment indications include endotoxemia and inflammation in end-stage renal disease (dialysis) patients, sepsis (a cause of hospital deaths), community-acquired pneumonia (a cause of death among infectious diseases), and emerging pandemic threats. Sigyn Therapy is a single-use disposable device that is deployable on the global infrastructure of hemodialysis and continuous renal replacement therapy (CRRT) machines. The Company’s development pipeline includes a cancer treatment system comprised of ChemoPrep to enhance the tumor site delivery of chemotherapy, and ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis.
- Revenue in USD (TTM)0.00
- Net income in USD-3.56m
- Incorporated2014
- Employees5.00
- LocationSigyn Therapeutics Inc9190 W Olympic Blvd # 263BEVERLY HILLS 90212United StatesUSA
- Phone+1 (619) 368-2000
- Fax+1 (845) 818-3588
- Websitehttps://www.sigyntherapeutics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ReShape Lifesciences Inc | 8.34m | -10.92m | 4.73m | 31.00 | -- | 1.04 | -- | 0.5674 | -2.30 | -2.30 | 0.7319 | 0.1933 | 0.6781 | 0.8178 | 4.52 | 268,871.00 | -88.83 | -136.06 | -162.20 | -194.32 | 65.85 | 56.30 | -130.99 | -408.36 | 1.26 | -- | 0.00 | -- | -22.79 | -0.9474 | 75.36 | -- | -49.29 | -- |
Nu-Med Plus Inc | 0.00 | -119.16k | 4.75m | 2.00 | -- | -- | -- | -- | -0.0014 | -0.0014 | 0.00 | -0.002 | 0.00 | -- | -- | 0.00 | -350.01 | -447.69 | -- | -- | -- | -- | -- | -- | -- | -22.74 | -- | -- | -- | -- | 3.56 | -- | -- | -- |
Aethlon Medical, Inc. | 0.00 | -12.21m | 5.11m | 14.00 | -- | 0.1676 | -- | -- | -4.87 | -4.87 | 0.00 | 2.19 | 0.00 | -- | -- | 0.00 | -94.80 | -76.25 | -108.90 | -85.78 | -- | -- | -- | -2,246.87 | -- | -- | 0.00 | -- | -100.00 | -- | -1.43 | -- | -- | -- |
Caduceus Software Systems Corp | 0.00 | -117.60k | 5.35m | 0.00 | -- | -- | -- | -- | -0.0004 | -0.0004 | 0.00 | -0.0004 | 0.00 | -- | -- | -- | -402.19 | -11,090.31 | -- | -- | -- | -- | -- | -- | -- | -76.88 | -- | -- | -- | -- | -20,519.89 | -- | -- | -- |
ADM Tronics Unlimited Inc | 2.97m | -877.23k | 5.35m | 7.00 | -- | 7.73 | -- | 1.81 | -0.013 | -0.013 | 0.0439 | 0.0102 | 1.13 | 4.89 | 7.04 | -- | -33.56 | -15.22 | -58.66 | -22.09 | 37.65 | 41.15 | -29.58 | -18.58 | 0.8015 | -316.56 | 0.4233 | -- | -19.35 | -0.3572 | -810.74 | -- | -- | -- |
Sonendo Inc | 40.19m | -57.74m | 5.39m | 216.00 | -- | 0.2197 | -- | 0.1341 | -0.6125 | -0.5552 | 0.426 | 0.3482 | 0.4448 | 2.07 | 7.58 | 186,055.60 | -63.91 | -- | -78.82 | -- | 27.64 | -- | -143.67 | -- | 2.14 | -10.83 | 0.4695 | -- | 5.30 | -- | -6.78 | -- | -- | -- |
Predictive Oncology Inc | 1.96m | -14.78m | 5.66m | 34.00 | -- | 1.38 | -- | 2.89 | -3.66 | -3.66 | 0.4853 | 0.9977 | 0.1099 | 1.71 | 4.95 | 57,642.65 | -82.89 | -91.80 | -108.54 | -126.29 | 64.18 | 64.64 | -754.19 | -1,419.99 | 1.35 | -- | 0.0093 | -- | 18.24 | 4.75 | 45.67 | -- | 5.44 | -- |
Biomerica Inc | 5.41m | -6.35m | 5.84m | 62.00 | -- | 0.748 | -- | 1.08 | -0.3789 | -0.3789 | 0.3224 | 0.4642 | 0.5827 | 2.28 | 5.74 | 87,180.80 | -68.45 | -43.55 | -83.73 | -50.32 | 11.41 | 15.75 | -117.46 | -55.86 | 3.37 | -- | 0.00 | -- | -71.71 | -0.8229 | -57.58 | -- | -9.76 | -- |
ALR Technologies Inc | 9.49k | -8.00m | 6.35m | 6.00 | -- | -- | -- | 669.62 | -0.0147 | -0.0147 | 0.00002 | -0.0476 | 0.0358 | -- | -- | 1,581.67 | -3,015.28 | -12,861.64 | -- | -- | 62.49 | -- | -84,283.24 | -406,011.30 | -- | -0.8626 | -- | -- | -- | -- | -42.72 | -- | -- | -- |
Sigyn Therapeutics Inc | 0.00 | -3.56m | 6.43m | 5.00 | -- | -- | -- | -- | -3.04 | -3.04 | 0.00 | -3.28 | 0.00 | -- | -- | 0.00 | -724.37 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0199 | -1.92 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
BioSig Technologies Inc | 27.00k | -25.25m | 6.49m | 4.00 | -- | -- | -- | 240.28 | -3.24 | -3.24 | 0.0033 | -0.3776 | 0.008 | -- | 1.74 | 6,750.00 | -728.65 | -269.73 | -- | -363.11 | 48.15 | -- | -91,566.66 | -24,485.73 | -- | -- | -- | -- | -93.71 | -- | -6.52 | -- | -9.58 | -- |
Telesis Bio Inc | 24.63m | -47.13m | 6.86m | 137.00 | -- | -- | -- | 0.2784 | -28.31 | -28.31 | 14.80 | 12.94 | 0.3231 | 3.27 | 5.58 | 179,802.90 | -59.34 | -- | -67.10 | -- | 60.43 | -- | -183.66 | -- | 3.08 | -35.89 | 0.2015 | -- | 0.2697 | -- | -1.14 | -- | -- | -- |
Innovative Eyewear Inc | 1.39m | -7.20m | 7.31m | 11.00 | -- | 0.8887 | -- | 5.25 | -12.15 | -12.15 | 2.35 | 5.90 | 0.2803 | 1.89 | 15.42 | 126,457.30 | -145.15 | -- | -168.75 | -- | -8.82 | -- | -517.88 | -- | 3.68 | -6,764.71 | 0.00 | -- | 74.67 | -- | -17.28 | -- | -- | -- |
Neurometrix Inc | 5.27m | -7.98m | 7.44m | 26.00 | -- | 0.392 | -- | 1.41 | -6.32 | -6.32 | 4.20 | 9.44 | 0.2381 | 1.25 | 10.08 | 202,700.40 | -36.07 | -23.24 | -38.94 | -27.26 | 61.97 | 59.17 | -151.51 | -48.88 | 10.11 | -- | 0.00 | -- | -28.52 | -18.18 | -47.84 | -- | 5.03 | -- |
Guided Therapeutics Inc | 82.00k | -3.23m | 7.74m | 4.00 | -- | -- | -- | 94.36 | -0.0623 | -0.0623 | 0.0016 | -0.0721 | 0.0374 | 0.0904 | 11.71 | 20,500.00 | -137.80 | -136.13 | -- | -- | 32.93 | 29.39 | -3,685.37 | -3,666.67 | 0.1138 | -11.13 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
Vivos Therapeutics Inc | 13.36m | -15.64m | 7.75m | 114.00 | -- | 11.26 | -- | 0.5796 | -11.00 | -11.00 | 8.73 | 0.2131 | 0.9247 | -- | 31.59 | 117,219.30 | -108.24 | -89.72 | -243.30 | -149.70 | 58.90 | 70.20 | -117.06 | -113.15 | -- | -- | 0.00 | -- | -13.87 | 29.48 | 43.04 | -- | -8.48 | -- |
Holder | Shares | % Held |
---|---|---|
Brio Capital Management LLCas of 09 Jan 2024 | 2.15k | 0.17% |